An effective vaccine against COVID-19 is need of the hour. India has been a hub for vaccine productions and Indian pharmaceutical companies have contributed immensely to the vaccine related projects running all over the world. Indian companies have also been pioneers in starting working on COVID-...
it is the largest clinical trial in India for a COVID-19 vaccine. The firm has generated safety and immunogenicity data in various animal species such as mice, rats, rabbits, Syrian hamster, and also conducted challenge
The milestones of COVID-19 vaccine development. With the maturity of vaccine platforms, more and more COVID-19 vaccines have entered clinical trials and been approved for emergency use in many countries. However, the appearance of VOCs has brought great challenges to existing COVID-19 vaccines. ...
Almost 90 percent of the shots were produced by the Serum Institute of India, which produced a version of the AstraZeneca vaccine. Take a look. Check out The China Report, our new weekly newsletter. Subscribe here! RELATED STORIES China's 5G mobile subscribers exceed 1 billion Technol...
COVAXIN®, India's indigenousCOVID-19 vaccineby Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech'sBSL-3 (Bio-Safety Level 3...
The cumulative COVID-19 vaccine doses administered in the country crossed 129 crore on Tuesday, the Union Health Ministry said. 联合国卫生部2019冠状病毒疾病疫苗接种量在星期二达到了129个月。 Over 66 lakh vaccine doses were administered on Tuesday till 7 pm, it said. ...
According to the ministry, about 96 percent of the population who are 15 and above have received at least one COVID-19 vaccine dose while about 83 percent of this group have received two doses.■
India and South Korea each have three vaccines, Japan has two vaccines, and Israel, Kazakhstan, Thailand, Turkey, Vietnam, and Iran each have one vaccine. Among these vaccines, there are ten inactivated vaccines, six protein subunit vaccines, seven viral vector vaccines, and six nucleic acid ...
The recent article "Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?" published on December 2 is thought provoking. The authors highlight critical disparities in the manufacture and distribution of COVID-19 vaccines although ...
Bharat Biotech in India has secured regulatory approval from the DCGI to advance its Covid-19 vaccine candidate, Covaxin, into human clinical trials.